Publications by authors named "Malcolm Finlayson"

Claim this Profile
P
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Eugenia Girda, June Hou, David Nelson, Malcolm Finlayson, Alexandre Buckley de Meritens

Int J Gynecol Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of CD44 Activity by A6-Peptide.
Malcolm Finlayson

Front Immunol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cells.
Randolph S Piotrowicz, Bassam B Damaj, Mohamed Hachicha, Francesca Incardona, Stephen B Howell, Malcolm Finlayson

Mol Cancer Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis